TaiMed Biologics to Present TMB-365 Data at IDWeek 2026
The company will present findings from a single-dose escalation study of TMB-365 and on resistance in the TMB-365/TMB-380 maintenance regimen in people living with HIV.
The company will present findings from a single-dose escalation study of TMB-365 and on resistance in the TMB-365/TMB-380 maintenance regimen in people living with HIV.